免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

BB-613-BPM

K 號:K241066 · 2025-01-14

決定日期2025-01-14
產品代碼DXN
諮詢委員會履歷
決定相當於

器材摘要

BB-613-BPM is the device name listed in this FDA 510(k) record. The listed applicant is Biobeat Technologies , Ltd.. It received FDA 510(k) clearance on 2025-01-14 under 510(k) number K241066. The device is classified under product code DXN. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the BB-613-BPM?

BB-613-BPM is a medical device that received FDA 510(k) clearance on 2025-01-14. The listed applicant is Biobeat Technologies , Ltd.. The 510(k) number is K241066.

When did BB-613-BPM receive FDA 510(k) clearance?

BB-613-BPM received FDA 510(k) clearance on 2025-01-14, under 510(k) number K241066.

Who is the listed applicant for BB-613-BPM?

The FDA 510(k) record lists Biobeat Technologies , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BB-613-BPM?

The FDA product code for BB-613-BPM is DXN.

其他以 Biobeat Technologies , Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DXN)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑